Literature DB >> 9632369

Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.

Y Huang1, P S Hammond, B R Whirrett, R J Kuhner, L Wu, S R Childers, R H Mach.   

Abstract

A series of N-(1-benzylpiperidin-4-yl)phenylacetamide derivatives was synthesized and evaluated for affinity at sigma1 and sigma2 receptors. Most of these compounds showed a high affinity for sigma1 receptors and a low to moderate affinity for sigma2 receptors. The unsubstituted compound N-(1-benzylpiperidin-4-yl)phenylacetamide, 1, displayed a high affinity and selectivity for sigma1 receptors (Ki values of 3.90 nM for sigma1 receptors and 240 nM for sigma2 receptors). The influence of substitutions on the phenylacetamide aromatic ring on binding at both the sigma1 and sigma2 receptor has been examined through Hansch-type quantitative structure-activity relationship (QSAR) studies. In general, all 3-substituted compounds, except for the OH group, had a higher affinity for both sigma1 and sigma2 receptors when compared with the corresponding 2- and 4-substituted analogues. The selectivity for sigma1 receptors displayed a trend of 3 > 2 approximately 4 for Cl, Br, F, NO2, and OMe substituted analogues. Halogen substitution on the aromatic ring generally increased the affinity for sigma2 receptors while maintaining a similar affinity for sigma1 receptors. Substitution with electron-donating groups, such as OH, OMe, or NH2, resulted in weak or negligible affinity for sigma2 receptors and a moderate affinity for sigma1 receptors. The 2-fluoro-substituted analogue, 11, exhibited the highest selectivity for sigma1 receptors among all compounds tested, with a Ki value of 3.56 nM for sigma1 receptors and 667 nM for sigma2 receptors. Compounds 1, 5, 9, 11, and 20 had no affinity for dopamine D2 (IC50 > 10 000 nM) and D3 (IC50 > 10 000 nM) receptors. The nanomolar binding affinity and high selectivity for sigma1 receptors suggest that these compounds may be developed as potential radiotracers for positron emission tomography or single photon emission computerized tomography imaging studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632369     DOI: 10.1021/jm980032l

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  Radiosynthesis and in vivo evaluation of a novel σ1 selective PET ligand.

Authors:  Hongjun Jin; Jinda Fan; Xiang Zhang; Junfeng Li; Hubert P Flores; Joel S Perlmutter; Stanley M Parsons; Zhude Tu
Journal:  Medchemcomm       Date:  2014-11-01       Impact factor: 3.597

2.  Chiral resolution of serial potent and selective σ1 ligands and biological evaluation of (-)-[18F]TZ3108 in rodent and the nonhuman primate brain.

Authors:  Xuyi Yue; Hongjun Jin; Zonghua Luo; Hui Liu; Xiang Zhang; Ethan D McSpadden; Linlin Tian; Hubert P Flores; Joel S Perlmutter; Stanley M Parsons; Zhude Tu
Journal:  Bioorg Med Chem       Date:  2017-01-16       Impact factor: 3.641

3.  The effects of sigma (σ1) receptor-selective ligands on muscarinic receptor antagonist-induced cognitive deficits in mice.

Authors:  Maninder Malik; Claudia Rangel-Barajas; Nathalie Sumien; Chang Su; Meharvan Singh; Zhenglan Chen; Ren-Qi Huang; Johann Meunier; Tangui Maurice; Robert H Mach; Robert R Luedtke
Journal:  Br J Pharmacol       Date:  2015-04-10       Impact factor: 8.739

4.  In vitro characterization of [3H]VAT in cells, animal and human brain tissues for vesicular acetylcholine transporter.

Authors:  Qianwa Liang; Sumit Joshi; Hui Liu; Yanbo Yu; Haiyang Zhao; Tammie L S Benzinger; Joel S Perlmutter; Zhude Tu
Journal:  Eur J Pharmacol       Date:  2021-10-07       Impact factor: 4.432

5.  Exploration of Sulfur-Containing Analogues for Imaging Vesicular Acetylcholine Transporter in the Brain.

Authors:  Zonghua Luo; Hui Liu; Hongjun Jin; Jiwei Gu; Yanbo Yu; Kota Kaneshige; Joel S Perlmutter; Stanley M Parsons; Zhude Tu
Journal:  ChemMedChem       Date:  2018-08-19       Impact factor: 3.466

6.  From α4β2 Nicotinic Ligands to the Discovery of σ1 Receptor Ligands: Pharmacophore Analysis and Rational Design.

Authors:  Li-Fang Yu; Han-Kun Zhang; Hendra Gunosewoyo; Alan P Kozikowski
Journal:  ACS Med Chem Lett       Date:  2012-12-13       Impact factor: 4.345

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.